B of A Securities Maintains Buy on DexCom, Lowers Price Target to $80

Benzinga Newsdesk www.benzinga.com Neutral 50.8%

Neg 0% Neu 50.8% Pos 0%

B of A Securities analyst Travis Steed maintains DexCom (NASDAQ:DXCM) with a Buy and lowers the price target from $100 to $80.